Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 17429

1.

Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.

Demark-Wahnefried W, Nix JW, Hunter GR, Rais-Bahrami S, Desmond RA, Chacko B, Morrow CD, Azrad M, Frugé AD, Tsuruta Y, Ptacek T, Tully SA, Segal R, Grizzle WE.

BMC Cancer. 2016 Feb 5;16(1):61.

PMID:
26850040
2.

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.

Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Banks KC, Lanman RB, Talasaz A, Parker BA, Kurzrock R.

Oncotarget. 2016 Feb 1. doi: 10.18632/oncotarget.7110. [Epub ahead of print]

PMID:
26848768
3.

New Prognostic Biomarkers in Patients With Traumatic Brain Injury.

Lorente L.

Arch Trauma Res. 2015 Dec 5;4(4):e30165. doi: 10.5812/atr.30165. eCollection 2015 Dec. Review.

PMID:
26848476
4.

Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.

O'Shannessy DJ, Davis DW, Anderes K, Somers EB.

Biomark Insights. 2016 Feb 1;11:7-18. doi: 10.4137/BMI.S35075. eCollection 2016.

PMID:
26848256
5.

Functional studies on circulating and disseminated tumor cells in carcinoma patients.

Alix-Panabières C, Bartkowiak K, Pantel K.

Mol Oncol. 2016 Jan 18. pii: S1574-7891(16)00014-4. doi: 10.1016/j.molonc.2016.01.004. [Epub ahead of print] Review.

PMID:
26847851
6.

Phase 1 study of PSMA-targeted docetaxel-containing nanoparticle BIND-014 in patients with advanced solid tumors.

Von Hoff D, Mita MM, Ramanathan RK, Weiss GJ, Mita AC, LoRusso PM, Burris HA 3rd, Hart LL, Low SC, Parsons DM, Zale SE, Youssoufian H, Summa J, Sachdev JC.

Clin Cancer Res. 2016 Feb 4. pii: clincanres.2548.2015. [Epub ahead of print]

PMID:
26847057
7.

Circulating DNA as a strong multi-marker prognostic tool for metastatic colorectal cancer patient management care.

El Messaoudi S, Mouliere F, Du Manoir S, Bascoul-Mollevi C, Gillet B, Nouaille M, Fiess C, Crapez E, Bibeau F, Theillet CG, Mazard T, Pezet D, Mathonnet M, Ychou M, Thierry AR.

Clin Cancer Res. 2016 Feb 4. pii: clincanres.0297.2015. [Epub ahead of print]

PMID:
26847055
8.

New and emerging developments in extensive-stage small cell lung cancer therapeutics.

Parikh M, Riess J, Lara PN Jr.

Curr Opin Oncol. 2016 Mar;28(2):97-103. doi: 10.1097/CCO.0000000000000264.

PMID:
26844984
9.

MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations.

Arena S, Siravegna G, Mussolin B, Kearns JD, Wolf BB, Misale S, Lazzari L, Bertotti A, Trusolino L, Adjei AA, Montagut C, Di Nicolantonio F, Nering R, Bardelli A.

Sci Transl Med. 2016 Feb 3;8(324):324ra14. doi: 10.1126/scitranslmed.aad5640.

PMID:
26843189
10.

A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.

Thierry AR.

Methods Mol Biol. 2016;1392:1-16. doi: 10.1007/978-1-4939-3360-0_1.

PMID:
26843041
11.

Bevacizumab specifically decreases elevated levels of circulating KIT+CD11b+ cells and IL-10 in metastatic breast cancer patients.

Cattin S, Fellay B, Pradervand S, Trojan A, Ruhstaller T, Rüegg C, Fürstenberger G.

Oncotarget. 2016 Jan 31. doi: 10.18632/oncotarget.7097. [Epub ahead of print]

PMID:
26840567
12.

Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer.

Cheng Y, Liu XQ, Fan Y, Liu YP, Liu Y, Liu Y, Ma LX, Liu XH, Li H, Bao HZ, Liu JJ, Zhang S, Wu CJ.

Future Oncol. 2016 Feb 3. [Epub ahead of print]

PMID:
26838372
13.

The "Liquid Biopsy": the Role of Circulating DNA and RNA in Central Nervous System Tumors.

Connolly ID, Li Y, Gephart MH, Nagpal S.

Curr Neurol Neurosci Rep. 2016 Mar;16(3):25. doi: 10.1007/s11910-016-0629-6.

PMID:
26838352
14.

Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.

Ling L, Lin Y, Zheng W, Hong S, Tang X, Zhao P, Li M, Ni J, Li C, Wang L, Jiang Y.

Sci Rep. 2016 Feb 3;6:20358. doi: 10.1038/srep20358.

PMID:
26837580
15.

Quantitative detection of the tumor-associated antigen large external antigen in colorectal cancer tissues and cells using quantum dot probe.

Wang S, Li W, Yuan D, Song J, Fang J.

Int J Nanomedicine. 2016 Jan 13;12:235-47. doi: 10.2147/IJN.S97509. eCollection 2016.

16.

Development of a Single Cell Migration and Extravasation Platform through Selective Surface Modification.

Roberts SA, Waziri AE, Agrawal N.

Anal Chem. 2016 Feb 2. [Epub ahead of print]

PMID:
26833093
17.

Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis.

Wu XL, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt Mde C.

Sci Rep. 2016 Feb 2;6:20210. doi: 10.1038/srep20210.

PMID:
26831813
18.

Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.

Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, Ewald AJ.

Proc Natl Acad Sci U S A. 2016 Feb 1. pii: 201508541. [Epub ahead of print]

PMID:
26831077
19.

Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.

Alkema NG, Wisman GB, van der Zee AG, van Vugt MA, de Jong S.

Drug Resist Updat. 2016 Jan;24:55-69. doi: 10.1016/j.drup.2015.11.005. Epub 2015 Nov 26.

PMID:
26830315
20.

Immunophenotyping of stage III melanoma reveals parameters associated with patient prognosis.

Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Semeraro M, Jégou S, Flores C, Chen L, Kwon BS, Borg C, Weide B, Aubin F, Dalle S, Kohrt H, Ayyoub M, Kroemer G, Marabelle A, Cavalcanti A, Eggermont A, Zitvogel L.

J Invest Dermatol. 2016 Jan 29. pii: S0022-202X(16)00366-3. doi: 10.1016/j.jid.2015.12.042. [Epub ahead of print]

PMID:
26829031
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk